Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             134 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparative study of the serological response to Japanese encephalitis vaccine in HIV-infected and uninfected Thai children Chokephaibulkit, Kulkanya
 2010
 28 Supplement 6 p. 3563-3566
4 p.
 artikel
2 A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia Carville, Kylie S.
 2010
 28 Supplement 6 p. 2532-2538
7 p.
 artikel
3 Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers van Dissel, Jaap T.
 2010
 28 Supplement 6 p. 3571-3581
11 p.
 artikel
4 Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children Passwell, Justen H.
 2010
 28 Supplement 6 p. 2231-2235
 artikel
5 A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep Chen, Weiye
 2010
 28 Supplement 6 p. 4742-4750
9 p.
 artikel
6 An active DNA vaccine against infectious pancreatic necrosis virus (IPNV) with a different mode of action than fish rhabdovirus DNA vaccines Cuesta, A.
 2010
 28 Supplement 6 p. 3291-3300
10 p.
 artikel
7 An analysis of the Human Papilloma Virus vaccine debate on MySpace blogs Keelan, Jennifer
 2010
 28 Supplement 6 p. 1535-1540
6 p.
 artikel
8 A novel adjuvant for vaccine development in the aged Morgan, Edward L.
 2010
 28 Supplement 6 p. 8275-8279
5 p.
 artikel
9 Antibody dynamics after tick-borne encephalitis and measles–mumps–rubella vaccination in children post early thymectomy Zlamy, Manuela
 2010
 28 Supplement 6 p. 8053-8060
8 p.
 artikel
10 Antibody persistence six years after two doses of combined hepatitis A and B vaccine Burgess, Margaret A.
 2010
 28 Supplement 6 p. 2222-2226
 artikel
11 Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children Pichichero, Michael E.
 2010
 28 Supplement 6 p. 7184-7192
9 p.
 artikel
12 Anti-preS responses influence the anti-HBs response in newborns after vaccination with the third generation Sci-B-Vac™ vaccine Sylvan, Staffan P.E.
 2009
 28 Supplement 6 p. 446-451
6 p.
 artikel
13 A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA Keiser, Paul B.
 2010
 28 Supplement 6 p. 6970-6976
7 p.
 artikel
14 A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens Saraya, Abhinbhen
 2010
 28 Supplement 6 p. 4553-4557
5 p.
 artikel
15 A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months Esposito, Susanna
 2010
 28 Supplement 6 p. 6137-6144
8 p.
 artikel
16 Are hard-to-reach populations being reached with immunization services? Findings from the 2005 Papua New Guinea national immunization coverage survey Toikilik, Steven
 2010
 28 Supplement 6 p. 4673-4679
7 p.
 artikel
17 A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines Talbird, Sandra E.
 2010
 28 Supplement 6 p. G3-G13
nvt p.
 artikel
18 A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine Conforti, Antonella
 2010
 28 Supplement 6 p. 3522-3530
9 p.
 artikel
19 A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children Zhu, Wei
 2010
 28 Supplement 6 p. 2865-2876
12 p.
 artikel
20 Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine Monsonego, J.
 2010
 28 Supplement 6 p. 8065-8072
8 p.
 artikel
21 Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs Dey, Bappaditya
 2009
 28 Supplement 6 p. 63-70
8 p.
 artikel
22 Carbohydrate moieties as vaccine candidates: Meeting summary Lucas, A.H.
 2010
 28 Supplement 6 p. 1121-1131
11 p.
 artikel
23 Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination Chlibek, Roman
 2010
 28 Supplement 6 p. 3758-3766
9 p.
 artikel
24 Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media Tsolakos, Nikos
 2010
 28 Supplement 6 p. 3211-3218
8 p.
 artikel
25 Chitosan-based nanoparticles for improving immunization against hepatitis B infection Prego, Cecilia
 2010
 28 Supplement 6 p. 2607-2614
8 p.
 artikel
26 Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines Steele, A.D.
 2010
 28 Supplement 6 p. 6542-6548
7 p.
 artikel
27 Combined peptides of human enterovirus 71 protect against virus infection in mice Liu, Jiang Ning
 2010
 28 Supplement 6 p. 7444-7451
8 p.
 artikel
28 Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen Jiao, Xu-dong
 2010
 28 Supplement 6 p. 1832-1837
6 p.
 artikel
29 Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV) Shen, H.G.
 2010
 28 Supplement 6 p. 5960-5966
7 p.
 artikel
30 Comparison of long-term humoral memory development after immunisation against Neisseria meningitidis B or diphtheria toxoid Cruz, Simone C.
 2010
 28 Supplement 6 p. 6841-6846
6 p.
 artikel
31 Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents Beran, Jiri
 2010
 28 Supplement 6 p. 5993-5997
5 p.
 artikel
32 Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age Halperin, Scott A.
 2010
 28 Supplement 6 p. 7865-7872
8 p.
 artikel
33 Complex cytokine profiles induced by BCG vaccination in UK infants Lalor, Maeve K.
 2010
 28 Supplement 6 p. 1635-1641
7 p.
 artikel
34 Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine Shanahan, Erin R.
 2010
 28 Supplement 6 p. 1341-1346
6 p.
 artikel
35 Development of novel lipidated analogs of picroside as vaccine adjuvants: Acylated analogs of picroside-II elicit strong Th1 and Th2 response to ovalbumin in mice Kumar, H.M. Sampath
 2010
 28 Supplement 6 p. 8327-8337
11 p.
 artikel
36 Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper Chandran, Dev
 2009
 28 Supplement 6 p. 132-139
8 p.
 artikel
37 Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI® Vilaplana, C.
 2010
 28 Supplement 6 p. 1106-1116
11 p.
 artikel
38 Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix Heldens, J.G.M.
 2010
 28 Supplement 6 p. 6989-6996
8 p.
 artikel
39 Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan de Blasio, Birgitte Freiesleben
 2010
 28 Supplement 6 p. 7923-7932
10 p.
 artikel
40 Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France Cohen, R.
 2010
 28 Supplement 6 p. 6114-6121
8 p.
 artikel
41 Economic impact of the introduction of an acellular pertussis vaccine in Canada: A 6-year analysis Iskedjian, Michael
 2010
 28 Supplement 6 p. 714-723
10 p.
 artikel
42 Editorial Board 2010
 28 Supplement 6 p. CO2-
1 p.
 artikel
43 Editorial Board 2010
 28 Supplement 6 p. CO2-
1 p.
 artikel
44 Editorial Board 2010
 28 Supplement 6 p. CO2-
1 p.
 artikel
45 Editorial Board 2009
 28 Supplement 6 p. CO2-
1 p.
 artikel
46 Editorial Board 2010
 28 Supplement 6 p. CO2-
1 p.
 artikel
47 Editorial Board 2010
 28 Supplement 6 p. CO2-
1 p.
 artikel
48 Editorial Board 2010
 28 Supplement 6 p. CO2-
1 p.
 artikel
49 Editorial Board 2010
 28 Supplement 6 p. CO2-
1 p.
 artikel
50 Editorial Board 2010
 28 Supplement 6 p. CO2-
1 p.
 artikel
51 Effect of genetic adjuvants on immune respondance, growth and hormone levels in somatostatin DNA vaccination-induced Hu lambs Xue, Chun-Lin
 2010
 28 Supplement 6 p. 1541-1546
6 p.
 artikel
52 Effect of oral immunization with pooled antigens derived from adipose tissue on atherosclerosis and obesity indices Bourinbaiar, Aldar S.
 2010
 28 Supplement 6 p. 2763-2768
6 p.
 artikel
53 Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination Soh, Shu E
 2010
 28 Supplement 6 p. 2577-2579
3 p.
 artikel
54 Effects of astragalus polysaccharides on immunologic function of erythrocyte in chickens infected with infectious bursa disease virus Jiang, Junbing
 2010
 28 Supplement 6 p. 5614-5616
3 p.
 artikel
55 Effects of maternal plasmid GHRH treatment on offspring growth Khan, Amir S.
 2010
 28 Supplement 6 p. 1905-1910
6 p.
 artikel
56 Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity Belshe, Robert B.
 2010
 28 Supplement 6 p. 2149-2156
8 p.
 artikel
57 Evaluation of particulate acellular vaccines against Brucella ovis infection in rams Da Costa Martins, Raquel
 2010
 28 Supplement 6 p. 3038-3046
9 p.
 artikel
58 Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits Heldens, J.G.M.
 2010
 28 Supplement 6 p. 8125-8131
7 p.
 artikel
59 Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine Yang, Chin-Fen
 2010
 28 Supplement 6 p. 5128-5134
7 p.
 artikel
60 Girls’ preferences for HPV vaccination: A discrete choice experiment de Bekker-Grob, Esther W.
 2010
 28 Supplement 6 p. 6692-6697
6 p.
 artikel
61 Haemophilus influenzae type b disease in HIV-infected children: A review of the disease epidemiology and effectiveness of Hib conjugate vaccines Mangtani, Punam
 2010
 28 Supplement 6 p. 1677-1683
7 p.
 artikel
62 Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge Chaganty, Bharat K.R.
 2010
 28 Supplement 6 p. 2323-2329
7 p.
 artikel
63 High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects Potsch, D.V.
 2010
 28 Supplement 6 p. 1447-1450
4 p.
 artikel
64 HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen Saenz, R.
 2010
 28 Supplement 6 p. 7556-7562
7 p.
 artikel
65 Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans Tan, Tze Guan
 2010
 28 Supplement 6 p. 3977-3989
13 p.
 artikel
66 Immunizing school-age children and adolescents: Experience from low- and middle-income countries Mackroth, Maria Sophia
 2010
 28 Supplement 6 p. 1138-1147
10 p.
 artikel
67 Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7 Caldeira, Jerri do Carmo
 2010
 28 Supplement 6 p. 4384-4393
10 p.
 artikel
68 Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents Lu, Chun-Yi
 2010
 28 Supplement 6 p. 5864-5870
7 p.
 artikel
69 Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years Tregnaghi, Miguel W.
 2010
 28 Supplement 6 p. 3595-3601
7 p.
 artikel
70 Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months Carmona, Alfonso
 2010
 28 Supplement 6 p. 5837-5844
8 p.
 artikel
71 Immunogenicity and safety of the human rotavirus vaccine Rotarix™ co-administered with routine infant vaccines following the vaccination schedules in Europe Vesikari, Timo
 2010
 28 Supplement 6 p. 5272-5279
8 p.
 artikel
72 Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia Souza, Alessandra R.
 2010
 28 Supplement 6 p. 1117-1120
4 p.
 artikel
73 Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy Esposito, Susanna
 2010
 28 Supplement 6 p. 1558-1565
8 p.
 artikel
74 Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland King Jr., James C.
 2010
 28 Supplement 6 p. 7737-7742
6 p.
 artikel
75 Incompletely matched influenza vaccine still provides protection in frail elderly Dean, Anna S.
 2010
 28 Supplement 6 p. 864-867
4 p.
 artikel
76 International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials Mast, T. Christopher
 2010
 28 Supplement 6 p. 950-957
8 p.
 artikel
77 Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara®) Roukens, Anna H.
 2010
 28 Supplement 6 p. 4288-4293
6 p.
 artikel
78 Intranasal immunization with Leish-111f induces IFN-γ production and protects mice from Leishmania major infection Sakai, Shun-ichi
 2010
 28 Supplement 6 p. 2207-2213
 artikel
79 Investigation on a pertussis outbreak in a military school: Risk factors and approach to vaccine efficacy Berger, F.
 2010
 28 Supplement 6 p. 5147-5152
6 p.
 artikel
80 In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6 von Teichman, Beate F.
 2010
 28 Supplement 6 p. 6505-6517
13 p.
 artikel
81 IRX-2 increases the T cell-specific immune response to protein/peptide vaccines Naylor, Paul H.
 2010
 28 Supplement 6 p. 7054-7062
9 p.
 artikel
82 J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells Taylor, P.R.
 2010
 28 Supplement 6 p. 5533-5542
10 p.
 artikel
83 Liposomal gD ectodomain (gD1–306) vaccine protects against HSV2 genital or rectal infection of female and male mice Olson, K.
 2009
 28 Supplement 6 p. 548-560
13 p.
 artikel
84 Live attenuated Salmonella enterica serovar Typhimurium expressing swine interferon-α has antiviral activity and alleviates clinical signs induced by infection with transmissible gastroenteritis virus in piglets Kim, Seon Ju
 2010
 28 Supplement 6 p. 5031-5037
7 p.
 artikel
85 Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve Cox, Sarah J.
 2010
 28 Supplement 6 p. 2318-2322
5 p.
 artikel
86 Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1 Feunou, Pascal Feunou
 2010
 28 Supplement 6 p. 7047-7053
7 p.
 artikel
87 Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51 Dubischar-Kastner, Katrin
 2010
 28 Supplement 6 p. 5197-5202
6 p.
 artikel
88 Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence Song, Joon Young
 2010
 28 Supplement 6 p. 3929-3935
7 p.
 artikel
89 Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1–11 years Marshall, Helen
 2010
 28 Supplement 6 p. 4411-4415
5 p.
 artikel
90 Middle- and high-school health education regarding adolescent vaccines and human papillomavirus Dempsey, Amanda F.
 2010
 28 Supplement 6 p. 7179-7183
5 p.
 artikel
91 Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster Brisson, Marc
 2010
 28 Supplement 6 p. 3385-3397
13 p.
 artikel
92 Modeling the national pediatric vaccine stockpile: Supply shortages, health impacts and cost consequences Shrestha, Sundar S.
 2010
 28 Supplement 6 p. 6318-6332
15 p.
 artikel
93 Modulation of inter-vaccination interval to avoid antigenic competition in multivalent footrot (Dichelobacter nodosus) vaccines in sheep Dhungyel, Om P.
 2009
 28 Supplement 6 p. 470-473
4 p.
 artikel
94 Mucosal perspectives in pneumococcal vaccine development: A meeting summary Wright, Adam K.A.
 2009
 28 Supplement 6 p. 2-6
5 p.
 artikel
95 Omission bias and vaccine rejection by parents of healthy children: Implications for the influenza A/H1N1 vaccination programme Brown, Katrina F.
 2010
 28 Supplement 6 p. 4181-4185
5 p.
 artikel
96 Oral vaccination with Ts87 DNA vaccine delivered by attenuated Salmonella typhimurium elicits a protective immune response against Trichinella spiralis larval challenge Yang, Yaping
 2010
 28 Supplement 6 p. 2735-2742
8 p.
 artikel
97 Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization Halliley, Jessica L.
 2010
 28 Supplement 6 p. 3582-3587
6 p.
 artikel
98 Platform technology to deliver prophylactic molecules orally: An example using the Class A select agent Yersinia pestis del Rio, Beatriz
 2010
 28 Supplement 6 p. 6714-6722
9 p.
 artikel
99 Population-based analysis of Actinobacillus pleuropneumoniae ApxIVA for use as a DIVA antigen O’Neill, Ciaragh
 2010
 28 Supplement 6 p. 4871-4874
4 p.
 artikel
100 Preputial cellular and antibody responses of bulls vaccinated and/or challenged with Tritrichomonas foetus Cobo, Eduardo R.
 2009
 28 Supplement 6 p. 361-370
10 p.
 artikel
101 Protective effect of ligand-binding domain of fibronectin-binding protein on mastitis induced by Staphylococcus aureus in mice Hu, Changmin
 2010
 28 Supplement 6 p. 4038-4044
7 p.
 artikel
102 Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States Rubin, Jaime L.
 2010
 28 Supplement 6 p. 7634-7643
10 p.
 artikel
103 Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines Wysocki, J.
 2010
 28 Supplement 6 p. 7779-7786
8 p.
 artikel
104 Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection Cummings, James F.
 2010
 28 Supplement 6 p. 5135-5144
10 p.
 artikel
105 Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17–18 February 2010 Girard, Marc P.
 2010
 28 Supplement 6 p. 6811-6820
10 p.
 artikel
106 Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1 Sealy, R.
 2010
 28 Supplement 6 p. 6749-6756
8 p.
 artikel
107 Rubella: Serosusceptibility among Egyptian females in late childhood and childbearing period Hashem, Mohamed
 2010
 28 Supplement 6 p. 7202-7206
5 p.
 artikel
108 Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up Dubischar-Kastner, Katrin
 2010
 28 Supplement 6 p. 6463-6469
7 p.
 artikel
109 Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: A prospective, open-label, multi-center trial Oh, Chi-Eun
 2010
 28 Supplement 6 p. 5857-5863
7 p.
 artikel
110 Safety and immunogenicity of single dose of tetanus–diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007 Bitragunta, Sailaja
 2010
 28 Supplement 6 p. 5934-5938
5 p.
 artikel
111 Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy Russell, F.M.
 2010
 28 Supplement 6 p. 3086-3094
9 p.
 artikel
112 Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis Black, Steven
 2010
 28 Supplement 6 p. 7331-7336
6 p.
 artikel
113 Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany Kieninger, Dorothee M.
 2010
 28 Supplement 6 p. 4192-4203
12 p.
 artikel
114 Salmonella enterica serovar Typhimurium ruvB mutant can confer protection against salmonellosis in mice Choi, Jeongjoon
 2010
 28 Supplement 6 p. 6436-6444
9 p.
 artikel
115 Seasonal influenza and vaccination coverage Monto, Arnold S.
 2010
 28 Supplement 6 p. D33-D44
nvt p.
 artikel
116 Serotype distribution of invasive pneumococcal disease during the first 60 days of life Imöhl, Matthias
 2010
 28 Supplement 6 p. 4758-4762
5 p.
 artikel
117 Signals elicited at the intestinal epithelium upon chitosan feeding contribute to immunomodulatory activity and biocompatibility of the polysaccharide Canali, M. Magdalena
 2010
 28 Supplement 6 p. 5718-5724
7 p.
 artikel
118 Single versus multi-dose vaccine vials: An economic computational model Lee, Bruce Y.
 2010
 28 Supplement 6 p. 5292-5300
9 p.
 artikel
119 Socioeconomic factors play a more important role in childhood vaccination coverage than parental perceptions: a cross-sectional study in Greece Danis, K.
 2010
 28 Supplement 6 p. 1861-1869
9 p.
 artikel
120 Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant Xue, Xiangyang
 2010
 28 Supplement 6 p. 3152-3158
7 p.
 artikel
121 Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region Lin, Tzou-Yien
 2010
 28 Supplement 6 p. 7589-7605
17 p.
 artikel
122 Survey of girls’ recall of a film providing information on human papillomavirus and cervical cancer 6 months after an offer of vaccination Brabin, Loretta
 2010
 28 Supplement 6 p. 4210-4214
5 p.
 artikel
123 Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs Peruzzi, Daniela
 2010
 28 Supplement 6 p. 1201-1208
8 p.
 artikel
124 The 2009 A (H1N1) influenza virus pandemic: A review Girard, Marc P.
 2010
 28 Supplement 6 p. 4895-4902
8 p.
 artikel
125 The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007 Bettinger, Julie A.
 2010
 28 Supplement 6 p. 2130-2136
7 p.
 artikel
126 The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species Cheru, Lediya
 2010
 28 Supplement 6 p. 4423-4429
7 p.
 artikel
127 The immunogenicity of intradermal influenza vaccination in COPD patients Chuaychoo, Benjamas
 2010
 28 Supplement 6 p. 4045-4051
7 p.
 artikel
128 Th2-polarisation of cellular immune memory to neonatal pertussis vaccination White, Olivia J.
 2010
 28 Supplement 6 p. 2648-2652
5 p.
 artikel
129 Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE Trigo, Joelma
 2010
 28 Supplement 6 p. 3333-3340
8 p.
 artikel
130 Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: Do children of all ages respond equally? Walter, Emmanuel B.
 2010
 28 Supplement 6 p. 4376-4383
8 p.
 artikel
131 Use of the Australian Childhood Immunisation Register for vaccine safety data linkage Gold, Michael
 2010
 28 Supplement 6 p. 4308-4311
4 p.
 artikel
132 Vaccination coverage against 2009 seasonal influenza in chronically ill children and adults: Analysis of population registries in primary care in Madrid (Spain) Rodríguez-Rieiro, Cristina
 2010
 28 Supplement 6 p. 6203-6209
7 p.
 artikel
133 Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras Ellingson, Joshua S.
 2010
 28 Supplement 6 p. 2679-2686
8 p.
 artikel
134 7-Valent pneumococcal conjugate vaccine and lower respiratory tract infections: Effectiveness of a 2-dose versus 3-dose primary series Pelton, Stephen I.
 2010
 28 Supplement 6 p. 1575-1582
8 p.
 artikel
                             134 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland